EBV LMP-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of EBV LMP-1 monoclonal antibodies for research focused on understanding the Epstein-Barr virus latent membrane protein 1 (LMP-1). EBV LMP-1 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LMP-1 is a critical oncoprotein that plays a significant role in the pathogenesis of EBV-associated malignancies, such as Hodgkin's lymphoma and nasopharyngeal carcinoma. By mimicking CD40 signaling, LMP-1 promotes cell proliferation and survival, contributing to the transformation of infected B cells. Understanding LMP-1 function is essential for developing targeted therapies and advancing knowledge of viral oncogenesis. EBV LMP-1 monoclonal antibodies enable detailed investigation of protein expression patterns and cellular localization. Researchers can utilize EBV LMP-1 monoclonal antibodies to examine protein-protein interactions and signaling pathways. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies support scientists worldwide in advancing EBV-related cancer research and therapeutic development.